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A B S T R A C T
Gut microbiota can impact liver disease development via the gut-liver axis. Liver inflammation is a shared
pathological event in various liver diseases and gut microbiota might influence this pathological process. In this
study, we studied the influence of gut microbiota on the inflammatory response of the liver to lipopolysaccharide
(LPS). The inflammatory response to LPS (1–10 μg/ml) of livers of specific-pathogen-free (SPF) or germ-free (GF)
mice was evaluated ex vivo, using precision-cut liver slices (PCLS). LPS induced a more pronounced in-
flammatory response in GF PCLS than in SPF PCLS. Baseline TNF-α gene expression was significantly higher in
GF slices as compared to SPF slices. LPS treatment induced TNF-α, IL-1β, IL-6 and iNOS expression in both SPF
and GF PCLS, but the increase was more intense in GF slices. The anti-inflammatory markers SOCS3 and IRAK-M
gene expression was significantly higher in GF PCLS than SPF PCLS at 24h with 1 µg/ml LPS treatment, and IL-10 was
not differently expressed in GF PCLS than SPF PCLS. In addition, TLR-4 mRNA, but not protein, at basal level was
higher in GF slices than in SPF slices. Taken together, this study shows that, in mice, the host microbiota
attenuates the pro-inflammatory impact of LPS in the liver, indicating a positive role of the gut microbiota on the
immune homeostasis of the liver.
1. Introduction
Inflammation of the liver, can be caused by alcohol abuse, viral
infections and the metabolic syndrome, and the gut-liver axis is widely
implicated in disease progression (Seki and Schwabe, 2015). Blood
from the gut can reach the liver via the hepatic portal vein carrying with
it microbiota-derived exogenous molecules (for example, lipopoly-
saccharide and lipoteichoic acid), also known as pathogen-associated
molecular patterns (PAMPs) (Chassaing et al., 2014). PAMPs are re-
cognized by pattern recognition receptors (PRRs), which are re-
sponsible for sensing invading pathogens and orchestrating the innate
immune response (Arrese et al., 2016; Takeuchi and Akira, 2010).
Toll like receptors (TLRs) are members of the PRR family. Until
now, 10 have been identified in human and 13 in mouse (West et al.,
2006). Among these TLRs, TLR-4 has attracted particular interest in
terms of hepatic inflammation and fibrogenesis due to its ligand, LPS,
which is involved in the development of various liver diseases (Su,
2002). TLR-4 is expressed in almost every type of liver cell, including
hepatocytes, Kupffer cells, hepatic stellate cells, biliary epithelial cells
and sinusoidal endothelial cells (Kesar and Odin, 2014).
Both in healthy and pathological conditions, the liver is involved in
the detoxification of LPS (Jirillo et al., 2002). In the healthy state, LPS
from gut microbiota penetrates the intestinal wall only in trace amounts
and is then cleared by Kupffer cells and hepatocytes, without inducing
significant liver inflammation (Szabo and Bala, 2010). In both alcoholic
and non-alcoholic liver disease patients, gut permeability is often in-
creased (Miele et al., 2009; Parlesak et al., 2000), thus accelerating
bacterial translocation to the liver (Parlesak et al., 2000). This facil-
itates an increased hepatic LPS translocation, which may act as a second
hit promoting disease progression. Binding of LPS to TLR-4 stimulates
the production of cytokines, such as tumor necrosis factor-α (TNF-α)
and interleukin-1β (IL-1β). These cytokines have been suggested to
https://doi.org/10.1016/j.tiv.2020.104920
Received 10 March 2020; Received in revised form 4 June 2020; Accepted 17 June 2020
⁎ Corresponding author at: Department of Pharmaceutical Technology and Biopharmacy, University of Groningen, Antonius Deusinglaan 1, 9713 AV Groningen,
the Netherlands.
E-mail address: p.olinga@rug.nl (P. Olinga).
Toxicology in Vitro 67 (2020) 104920
Available online 24 June 2020
0887-2333/ © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
drive the pathogenesis of alcoholic liver disease, nonalcoholic steato-
hepatitis and nonalcoholic fatty liver disease (Bugianesi et al., 2005;
Miura et al., 2010; Tilg et al., 2016).
Germ free (GF) rodent is a popular model to study the gut-liver axis.
In GF mice, the liver has limited history of LPS exposure, while in co-
lonized (specific-pathogen-free, SPF) mice the liver is subjected to LPS
(Caesar et al., 2012). The aim of this study is to investigate the influ-
ence of the gut microbiota on the inflammatory response of the liver to
LPS. We hypothesize that the liver of SPF mice will respond less severe
to LPS than the liver of GF mice. As a model, we used precision-cut liver
slices (PCLS). Previously, we have shown that PCLS can be used as a
multicellular model to study LPS-induced inflammation of the liver
since hepatocytes, Kupffer cells and other (non)-parenchymal cells are
still present in their original tissue environment (Olinga et al., 2001).
This makes PCLS a unique model to study the innate immunity in the
liver. To investigate the role of gut microbiota in facilitating tolerance
of the liver to LPS, we compared the effect of LPS in PCLS from SPF and
GF mice. These experiments will provide additional insight into the
interaction between the liver and gut microbiota.
2. Materials and methods
2.1. Animals
Use of murine tissue for the preparation of PCLS was approved by
the Animal Ethical Committee of University of Groningen (DEC
6416AA-001). Germ free C57BL/6 mice were housed in isolators at the
Central Animal Facility of the University Medical Center Groningen and
provided with sterile rodent chow diet and water ad libitum. Specific-
pathogen-free C57BL/6 mice were purchased from Harlan (Zeist, The
Netherlands) and were provided standard rodent chow diet and water.
All mice were allowed to acclimatize at least 1 week prior to the ex-
periments. Mice were sacrificed under 2% isofluorane/O2 (Nicholas
Piramal, London, UK) anesthesia, at the age of 8–10 weeks. Livers of the
mice were resected immediately after sacrificing and stored in ice-cold
University of Wisconsin (UW) organ preservation solution (DuPont
Critical care, Waukegab, IL, USA.).
2.2. Preparation of mouse liver slices
Cylindrical cores of liver tissue were obtained using a 6 mm dia-
meter biopsy punch and preserved in ice-cold UW solution. Precision-
cut liver slices (PCLS) were prepared in Krebs-Henseleit buffer supple-
mented with 25 mM D-glucose (Merck, Darmstadt, Germany), 25 mM
NaHCO3 (Merck) and 10 mM 4-(2-hydroxyethyl)piperazine-1-ethane-
sulfonic acid (MP Biomedicals, Ohio, USA), oxygenated with 95% O2
and 5% CO2 using a Krumdieck tissue slicer as previously described (de
Graaf et al., 2010). Liver slices had a wet weight of 4–5 mg, with a
thickness of approximately 250 μm.
2.3. Incubation of mouse liver slices
After slicing, PCLS were incubated individually in 12 well plates
containing William's E medium with GlutaMAX (Life Technologies,
Carlsbad, USA) supplemented with 2.75 g/ml D-glucose monohydrate
(Merck, Darmstadt, Germany) and 50 μg/ml gentamicin (Invitrogen,
Paislely, UK). PCLS were incubated for 1 h to restore viability and ATP
content. To assess the full phenomena of LPS stimulation, slices were
incubated for 48 h with 0, 1 or 10 μg/ml ultrapure LPS from Escherichia
coli O111:B4 (InvivoGen, Toulouse, France) (Olinga et al., 2001).
Medium was refreshed every 24 h. The plates were incubated in a
shaking incubator (90 cycles/min) with continuous 5% CO2 and 80%
O2 supply.
2.4. Viability of mouse liver slices
For ATP analysis, slices were kept in 1 ml sonification solution (70%
(vol/vol) ethanol (VWR, Paris, France), 2 mM EDTA (Merck), pH 10.9)
(de Graaf et al., 2010), snap-frozen, and stored at −80 °C. The samples
were homogenized using a Mini-Beadbeater (BioSpec Products, Bar-
tlesville, USA) and centrifuged. Clear supernatant was used for ATP
analysis and the remaining pellet for protein determination. ATP con-
tent of each slice was determined using the ATP bioluminescence assay
kit class II (Roche Diagnostics GmbH, Mannheim, Germany) as pre-
viously described (de Graaf et al., 2010). Protein content of each slice
was determined using the DC™ Protein Assay (Biorad, Veenendaal, the
Netherlands) according to the manufacturer's instruction.
2.5. Quantitative real-time polymerase chain reaction
Total RNA, from pooled (n = 3) slices, was extracted using the
FavorPrep tissue total RNA mini kit (FAVORGEN Biotech Corp, Vienna,
Austria) according to the manufacturer's instructions and stored at
−80 °C. RNA concentration was determined using the Synergy HT
(Biotek, Swindon, UK) at a wavelength of 260/280. Total RNA (1 μg)
was transcribed into cDNA using the Reverse Transcription Kit
(Promega, Leiden, the Netherlands) following the manufacturer's in-
structions and stored at −20 °C. Gene expression was determined by
either the SYBR Green or Taqman method (Roche Diagnostics GmbH,
Mannheim, Germany) using gene specific primers (Supplementary
Table I). Expression of each gene was normalized using the reference
gene GAPDH (ΔCt) and expressed as percentage ((2−ΔCt) *100).
2.6. ELISA and NOx colorimetric assay
Culture medium from 3 PCLS was pooled together after 0-24 h and
24-48 h incubation and stored at −20 °C. Concentrations of TNF-α and
IL-1β were measured using the DuoSet® ELISA Development Systems (R
&D Systems, Abingdon, UK) according to the manufacturer's protocol.
Nitrate/nitrite (NOx) was determined by a colorimetric assay according
to Moshage et al. (Moshage et al., 1995).
2.7. Western blotting
TLR-4 protein expression was determined by immunoblotting. PCLS
(n = 3) were lysed in RIPA Lysis and Extraction Buffer (Thermo Fisher
Scientific, Waltham, USA). Membranes were incubated with a TLR-4
antibody at 4 °C overnight, followed by incubation with a secondary
antibody at room temperature for 1 h (Supplementary Table II for de-
tails for the antibodies). The protein signal was visualized with
VisiGlo™ Prime HRP Chemiluminescent Substrate Kit (Amresco, Ohio,
USA) and quantified with Image Lab software (Biorad, Veenendaal, the
Netherlands).
2.8. Morphology
PCLS were incubated with or without LPS for 48 h. Slices, processed
directly after slicing for morphological analysis, PCLS were fixed in 4%
formaldehyde overnight and stored at 4 °C in 70% ethanol. Fixed slices
were dehydrated, embedded in paraffin, sectioned (4 μm) and stained
with hematoxylin and eosin as previously described (Hadi et al., 2013).
2.9. Statistics
Results are expressed as mean ± standard error of the mean (SEM).
Student's t-test or ANOVA followed by Fisher's LSD multiple compar-
isons test were performed using Graphpad Prism 6.0 (La Jolla, CA,
USA). A p-value of< 0.05 was considered significant when comparing
differences between groups.
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3. Results
3.1. Viability of liver slices from GF and SPF mice
The ATP content of PCLS, as a measure of viability, was determined
after culturing. As shown, slices remained viable for 48 h (Fig. 1A&B).
Exposure of SPF liver to LPS for 48 h slightly lowered the ATP content
(Fig. 1A) and caused the appearance of apoptotic cells (Fig. 1B). In
contrast, treatment of GF liver slices with LPS for 48 h markedly re-
duced ATP levels (Fig. 1A) and resulted in the presence of necrotic areas
(Fig. 1B). These data show that PCLS from SPF mice are more tolerant
to LPS challenge than those from GF mice.
3.2. Expression of cytokines in GF and SPF mouse liver slices upon LPS
challenge
To evaluate the inflammatory response of the liver after LPS chal-
lenge, gene expression of TNF-α, IL-1β, IL-6 and iNOS was determined
(Fig. 2). Prior to culturing, TNF-α gene expression was 1.75-fold higher
in GF compared to SPF PCLS; whereas the expression of IL-1β, IL-6 and
iNOS did not differ (Supplementary Fig. II). During incubation without
LPS for 48 h, an inflammatory response was induced in PCLS, as illu-
strated by an increase in the gene expression of TNF-α, IL-1β, IL-6 and
iNOS in both GF and SPF PCLS (Supplementary Fig. II).
Upon LPS treatment, TNF-α gene expression increased in both GF
and SPF mouse PCLS up to 24 h; this phenomenon was much stronger in
GF PCLS than SPF PCLS. At 48 h, LPS did not significantly increase TNF-
α gene expression in SPF PCLS, while in GF PCLS, LPS did induce TNF-α
gene expression (Fig. 2). iNOS expression was higher in GF PCLS than
SPF PCLS at 24 h and 48 h, while the expression of IL-1β and IL-6 was
higher in GF PCLS than SPF PCLS at 48 h.
After 24 h of incubation of both SPF and GF PCLS, TNF-α and IL-1β
cytokine release was markedly elevated in LPS challenged groups
(Fig. 3). LPS evoked bigger extent of TNF-α secretion in the GF than SPF
PCLS, but the IL-1β response was similar in both groups. Between 24
and 48 h, we did not detect any increase in cytokine release following
LPS challenge in both GF and SPF slices (Fig. 4). LPS significantly in-
creased NOx production in GF PCLS both after 0–24 and 24-48 h in-
cubation, while in SPF slices we observed a small but non-significant
increase. Taken together, these data indicate that LPS treatment evokes
Fig. 1. Viability and morphology of PCLS. (A) Viability of PCLS was determined
by ATP/protein (pmol/ μg) content. Data are shown as mean ± SEM; three
PCLS were used for each group in both GF mice (n = 3–5) and SPF mice
(n = 3–5). ** p <0 .01 and *** p <0 .001. (B) H&E staining of PCLS after
48 h incubation with or without LPS; arrows: necrotic area. GF mice (n = 3)
and SPF mice (n = 3), scale bar = 50 μm.
Fig. 2. The effect of LPS on mRNA levels of TNF-α, IL-1β, IL-6 and iNOS in PCLS
from GF and SPF mice. mRNA levels of the above-mentioned genes were
measured with qRT-PCR. Data are shown as mean ± SEM; three PCLS for each
condition were pooled for RNA isolation. After slicing: GF (n = 6), SPF (n = 6);
24 h and 48 h: GF (n = 3), SPF (n = 3). *p <0.05, **p <0 .01,
***p <0 .001 and ****p <0 .0001.
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a stronger inflammatory response in GF liver slices than in SPF liver
slices.
3.3. LPS receptor TLR-4 mRNA but not protein expression was lower in SPF
mice
To elucidate why SPF PCLS are more tolerant to LPS challenge, we
examined the expression of the LPS receptor TLR-4. At baseline, TLR-4
gene expression in SPF PCLS was significantly lower as compared to GF
PCLS (Fig. 5), but this difference disappeared after 24 h of culturing. In
SPF mice, both 1 and 10 μg/ml LPS reduced the expression of TLR-4 at
24 h, but not in GF mice. At 48 h, LPS did not impact TLR-4 mRNA
levels. The baseline expression of TLR-4 protein was not different be-
tween SPF versus GF slices, and also not different during incubation
with or without LPS challenge (Fig. 6). Taken together, the divergent
responses to LPS cannot be explained by differences in TLR-4 mRNA
expression.
3.4. Anti-inflammatory status in GF and SPF mouse liver slices upon LPS
challenge
The expression of the anti-inflammatory mediators IL-10, IRAK-M
and SOCS3 was determined by qRT-PCR to elucidate whether these
factors cause the different responses to LPS observed in SPF and GF
PCLS (Fig. 7). IL-10, IRAK-M and SOCS3 were not differently expressed
at baseline in GF versus SPF PCLS. During incubation, there was upre-
gulation of SOCS3 and IRAK-M in SPF PCLS, IRAK-M in GF mice, no
significant change in the expression of IL-10 in both GF and SPF PCLS
(Supplementary fig. III). LPS increased the expression of IL-10, IRAK-M
and SOCS3 both in GF and SPF PCLS. For IL-10, this increase was much
higher after 48 h than after 24 h, whereas for SOCS3 and IRAK-M, the
opposite was true. Nevertheless, SOCS3 and IRAK-M gene expression
was higher in GF PCLS than SPF PCLS at 24 h with 1 μg/ml LPS
treatment, and IL-10 was not differently expressed in GF PCLS than SPF
PCLS at. Surprisingly, SPF PCLS did not express more anti-inflammatory
mediators than GF PCLS in response to LPS stimuli.
4. Discussion
Liver inflammation is an underlying pathology in various liver dis-
eases. Interaction between the liver and gut microbiota (the gut-liver
axis) is an emerging but not fully understood topic. In this study, the
relationship between liver inflammation and gut microbiota was in-
vestigated using an ex vivo model of liver inflammation in GF and SPF
Fig. 3. The effect of LPS on protein release of TNF-α and IL-1β of PCLS from GF
and SPF mice. Protein levels of TNF-α and IL-1β were measured in the culture
medium from 0 to 24 h and from 24 to 48 h using ELISA. Cytokine release from
LPS treated groups are expressed as relative value to the control group of GF or
SPF mice after 24 h incubation. Data are shown as mean ± SEM; culture
medium from three PCLS was pooled to represent each condition in GF mice
(n = 3), SPF mice (n = 4–5). *p < 0 .05, **p <0 .01.
Fig. 4. The effect of LPS on nitrite/nitrate (NOx) production of PCLS from GF
and SPF mice. Nitrite/nitrate (NOx) content in the culture medium from 0 to
24 h and from 24 to 48 h was determined using the NOx colorimetric assay.
Data are shown as mean ± SEM; culture medium from three PCLS was pooled
to represent each condition in GF mice (n = 5), SPF mice (n = 9). *p < 0 .05,
** p < 0 .01.
Fig. 5. The effect of LPS on mRNA levels of TLR-4 in PCLS from GF and SPF
mice. mRNA level of TLR-4 was measured with qRT-PCR. Data are shown as
mean ± SEM; three PCLS for each condition were pooled for RNA isolation.
After slicing: GF (n = 6), SPF (n = 6); 24 h and 48 h: GF (n = 3), SPF (n = 3).
*p < 0 .05, **p < 0 .01.
Fig. 6. The effect of LPS on protein level of TLR-4 in PCLS from GF and SPF
mice. TLR-4 protein in PCLS from GF or SPF mice was measured by Western
blotting. (A) Representative Western blots of TLR-4 expression at baseline and
during incubation. (B) Average protein expression normalized to total protein
loaded (Supplementary fig. I.). Data are shown as mean ± SEM; three PCLS for
each condition were pooled for protein isolation. After slicing: GF (n = 6), SPF
(n = 6); 24 h and 48 h: GF (n = 3), SPF (n = 3). *p < 0 .05.
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mice. The data revealed that the presence of host microbiota attenuates
the proinflammatory impact of LPS in the liver, by decreasing proin-
flammatory responses and improving cell survival even in the absence
of circulating immune cells.
Our results demonstrated that PCLS from SPF mice are less vul-
nerable to an LPS challenge than PCLS from GF mice (Fig. 1). Pre-
viously, it has been shown that LPS leads to moderate tissue damage in
SPF rat liver slices (Olinga et al., 2001), proposed to be mediated ex-
clusively by TNF-α (Nowak et al., 2000). Since LPS evoked a more
robust TNF-α in GF slices compared to SPF slices (Fig. 3), this might
explain the worse survival of GF PCLS after LPS treatment.
The LPS-induced inflammatory response was more pronounced in
GF PCLS as compared to SPF PCLS (Fig. 2-4). In SPF mice, LPS elevated
TNF-α and IL-1β cytokine release during the first 24 h, however the
slices did not produce any cytokines in the subsequent period, even
though gene levels remained elevated. A similar observation was made
in GF slices; however, it cannot be excluded that the reduction in cy-
tokine production is due to changes in viability. The lack of TNF- α
protein production between 24 and 48 h indicates a transient expres-
sion (Chanput et al., 2010), and this observation may be explained via
the mechanism of endotoxin tolerance. Pena et al. found that restimu-
lation of human mononuclear cells by LPS 24 h after the initial sti-
mulation did not increase TNF-α gene expression and cytokine release
(Pena et al., 2011). Similarly, Sun et al. showed in a human monocyte
cell line (THP-1 cells) that restimulation with LPS did not enhance TNF-
α and IL-1β cytokine production (Sun et al., 2014).
TLR-4 is tightly regulated to avoid uncontrolled inflammation and
extensive tissue damage. In this study, LPS had the tendency to lower
the gene expression of TLR-4 in both GF and SPF liver slices (Fig. 5).
This is in agreement with Poltorak et al.'s finding that LPS strongly and
transiently suppressed TLR-4 mRNA expression (Poltorak et al., 1998).
Recent in vivo lung and in vitro macrophage studies argued that LPS
shortens the half-life of TLR-4 mRNA (Fan et al., 2002). Decreased TLR-
4 expression was reported to be associated with a tolerance towards LPS
in neutrophils (Parker et al., 2005). Takahashi et al. showed that
commensal microbiota are essential for epigenetic repression (via high
methylation of the promoter) of TLR-4 mRNA expression in large in-
testinal epithelial cells, which was associated with a reduced in-
flammatory response of the intestine to LPS challenge (Takahashi et al.,
2011). They also suggested that the responsiveness of intestinal epi-
thelial cells to LPS is mainly regulated at the transcriptional level for
TLR-4, although there might be additional post-transcriptional regula-
tion present (Takahashi et al., 2009). The present study showed that
TLR-4 mRNA expression was higher in GF than SPF mice, which might
correlate with the observed responsiveness to LPS. However, protein
expression of TLR-4 was not different between SPF and GF PCLS at
baseline and during incubation, thus TLR-4 expression cannot fully
explain the hyper-responsiveness of GF to LPS.
Divergent response to LPS was seen in GF and SPF slices. We hy-
pothesized that SPF mice livers produce more anti-inflammatory med-
iators than GF upon LPS stimuli, so that the inflammation in the SPF
mice is more negatively regulated than GF. IL-10 is an anti-in-
flammatory cytokine that regulates LPS tolerance (Iyer and Cheng,
2012). Interleukin-1 receptor-associated kinase-M (IRAK-M) is a serine/
Fig. 7. The effect of LPS on mRNA levels of IL-10, SOCS3, IRAK-M in PCLS from GF and SPF mice. Expression of the above-mentioned genes was measured with qRT-
PCR. Data are shown as mean ± SEM; three PCLS for each condition were pooled for RNA isolation. After slicing: GF (n = 6), SPF (n = 6); 24 h and 48 h: GF
(n = 3), SPF (n = 3). *p < 0 .05.
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threonine kinase that negatively regulates TLR signaling (Kobayashi
et al., 2002). Suppressor of cytokine signaling-3 (SOCS3) negatively
regulates cytokine signaling through blocking Janus kinases (JAK) ac-
tivity (Kubo et al., 2003). Previously it has been shown that higher
expression of IL-10, SOCS3 and IRAK-M is associated with LPS tolerance
(Biswas and Lopez-Collazo, 2009). Thus, IL-10, IRAK-M and SOCS3 can
be used as anti-inflammatory markers that regulate LPS responsiveness.
In vivo IL-10 expression is upregulated following LPS administration,
and functions to prevent excessive inflammation and protect against
lethal amount of LPS stimulus (Berg et al., 1995; Berlato et al., 2002;
Iyer et al., 2010). This process is potentially mediated by SOCS3
(Berlato et al., 2002; Biswas and Lopez-Collazo, 2009). IRAK- M is a
negative regulator of the downstream signaling of TLR-4 after LPS sti-
muli. IRAK- M expression is increased by LPS and in LPS tolerant status
(van 't Veer et al., 2007). Although these markers (IL-10, IRAK-M and
SOCS3) are generally suggested to be negative regulators of the TLR
pathway, the regulation of these genes and their induction kinetics are
not completely understood. TNF-α upregulates SOCS3 and IRAK-M
expression in macrophages in vitro (Bode et al., 1999; van 't Veer et al.,
2007). The expression of SOCS3 is parallel to the proinflammatory
cytokines (IL-1β, ΤΝF-a and IL-6) in periodontal LPS model in vivo
(Chaves de Souza et al., 2013). Kiyono et al. demonstrated in vivo that
LPS administration in GF mice induces a higher and prolonged anti-LPS
hemagglutinin titer than in conventional mice (Kiyono et al., 1980);
and suggested that GF mice might lack a population of T lymphocytes
that suppress the LPS response. SOCS3 and IRAK-M are expressed on T
lymphocytes and regulates innate immunity (Yu et al., 2013; Zhang
et al., 2017). In the PCLS-LPS model, upregulation of SOCS3 and IRAK-
M did not show a clear parallel pattern with TNF-α, which might due to
a lack of circulating T lymphocytes or other immune cells in the PCLS.
Based on the presented data we found no indication that these anti-
inflammatory mediators are responsible for the different LPS response
between GF and SPF PCLS. Already in 1980, J.R. McGhee et al found
that in vitro stimulation of splenocytes of GF mice gave 2- to 3-fold
greater mitogenic stimulation than those observed in conventional
spleen cells, in addition, lower responses to LPS were observed after
conventionalization of GF mice with indigenous BALB/c flora, and
suggested that these phenomena are associated with T cell population
that regulates B cell responses to LPS (McGhee et al., 1980). Mitsuyama
et al. suggested that the microbiota may play a role in regulating
macrophage functionality (Mitsuyama et al., 1986); impaired or re-
duced phagocytosis of peritoneal macrophages was reported under
stimulation of LPS in vitro or in vivo (Morland et al., 1979). Thus,
macrophages in GF PCLS may not be fully developed and therefore
cannot execute the complex tasks needed to control the response to LPS.
In a later study in vivo, injection of LPS induced less serum levels of
TNF-α, IL-1β, IL-6 and greater corticosterone levels in GF compared to
conventional mice. They speculated that high levels of serum corti-
costerone in GF might responsible for the lower responsiveness of in-
flammatory cytokines (Ikeda et al., 1999). A more recent study in
periodontal tissue showed that local administration of LPS induced
higher TNF-α expression in SPF mice and suggested that GF mice may
be populated with decreased numbers of dendritic cells and macro-
phages that are the major cells producing cytokines and chemokines
(Fukuhara et al., 2018). In contrast with these two in vivo observations,
in the current study, the pro-inflammatory response of GF PCLS is
greater than SPF, which might due to the lack of circulating immune
cells or hormones which can influence immune reaction in PCLS com-
pared to the in vivo situation. To our knowledge, no study previously
compared the liver inflammation between SPF and GF mice upon LPS
stimuli.
It is well-known that the gut microbiota influences host develop-
ment and physiology, although it is unclear which signaling pathways
are involved (Sommer and Backhed, 2013). The negative impact of gut
microbiota on the development of different liver diseases is an emer-
ging topic (Federico et al., 2016; Seki et al., 2007; Seki and Schnabl,
2012). However, it has also been described that the absence of gut
microbiota contributes to liver pathology (Chen et al., 2015; Mazagova
et al., 2015; Tabibian et al., 2016). The microbiota can be a double-
edged sword. To illustrate, germ-free mice are resistant to diet-induced
obesity (Backhed et al., 2007), but they are also more susceptible to
chemical-induced liver fibrosis (Mazagova et al., 2015), alcohol-in-
duced liver injury (Chen et al., 2015) and biliary injury (Tabibian et al.,
2016), suggesting that the microbiota elicits hepatoprotective effects of
microbiota. In accordance with these observations, we have shown in
this study that LPS evokes a stronger pro-inflammatory response in GF
PCLS than in SPF PCLS. The inflammatory response in GF PCLS was
accompanied by a loss of viability, while SPF slices were less prone to
LPS-induced damage, which may indicate that SPF PCLS develop tol-
erance against LPS when compared to GF PCLS. Since PCLS lack cir-
culating immune cells the divergent response to LPS in GF and SPF
slices is mediated by resident cells, this indicates that there is a close
interaction between the gut and the hepatic innate immune system.
Whilst LPS is considered the main microbiota-derived PAMP, it
would be of additional value to test other PAMPs to elucidate the or-
ganization and interaction of the liver's innate inflammatory response.
Additionally, this study is based on an ex vivo model lacking circulating
immune cells; adding immune cells to PCLS during incubation would
aid in revealing the potential involvement of circulating immune cells
in the inflammatory response of the liver. Lastly, in vivo studies could be
designed to implant specific gram-negative or gram-positive bacteria in
GF mice, to explore the contribution of these microbes on the in-
flammatory response in PCLS.
5. Conclusion
This study reveals that the presence of host microbiota mitigates the
inflammatory response to LPS in the liver, by decreasing inflammatory
processes and preventing cell death, even in the absence of circulating
immune cells. Still, more research is needed to further unravel the re-
lationship between the gut microbiota and the hepatic innate immune
system.
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